Importantly, given the established associations of NF1 and SDHx variants with hereditary tumor syndromes, the identification of either SDH-deficient or NF1-related GISTs should always prompt genetic counseling to guide appropriate genetic testing, interpret variants of uncertain significance, and provide information for patient and family risk assessment and management. Here, SDHB is linked to hereditary neoplastic syndrome.